Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

EnteroMedics acknowledges mixed results for obesity device pivotal trial
FierceMedicalDevice
Thursday, February 7, 2013 - 9:19pm
tags:
EnteroMedics, obesity, devices, clinical trials
Stryker crushes Zimmer with $70M patent violation verdict
FierceMedicalDevice
Thursday, February 7, 2013 - 9:18pm
tags:
Stryker, patent, Zimmer, legal, Device
Top 10 device and diagnostic FDA approvals of 2012
FierceMedicalDevice
Thursday, February 7, 2013 - 9:12pm
tags:
FDA, regulatory, devices
Stereotaxis CFO Steps Down to Pursue New Career Opportunity
Yahoo/GlobeNewswire
Thursday, February 7, 2013 - 9:08pm
tags:
Stereotaxis, CFO, Management
RTI Biologics Announces 2012 Fourth Quarter, Full Year Results, 2013 Financial Guidance
Yahoo/BusinessWire
Thursday, February 7, 2013 - 9:07pm
tags:
RTI Biologics, earnings, devices
Misonix Reports Financial Results for First Half of Fiscal 2013
Yahoo/PRNewswire
Thursday, February 7, 2013 - 9:07pm
tags:
Misonix, earnings, devices
Senators push to repeal U.S. medical device tax; success unlikely
Reuters
Thursday, February 7, 2013 - 9:05pm
tags:
US, device tax, legal, congress, government
BIOLASE Issued Broad New Patent for Treating Eye Conditions, Including Presbyopia, Cataracts, and Glaucoma
Yahoo/MarketWire
Thursday, February 7, 2013 - 9:00pm
tags:
treatment, patent, devices, eye, cataracts
Zhengzhou neurosurgeons perform first iMRI case in VISIUS® Surgical Theatre
Yahoo/PRNewswire
Thursday, February 7, 2013 - 8:59pm
tags:
Visius Surgical, MRI, devices
CareFusion Reports First Half Fiscal 2013 Results
Yahoo/PRNewswire
Thursday, February 7, 2013 - 8:58pm
tags:
CareFusion, earnings, devices
Two-Year Clinical Study Supports Safety and Efficacy of Covidien Solitaire™ FR Revascularization Device
Yahoo/BusinessWire
Thursday, February 7, 2013 - 8:57pm
tags:
clinical study, research, Covidien, Solitaire
Elan seeks acquisitions after $3.25 bn Biogen Idec deal, rival Bayer eyed on MS treatments
Financial Express
Thursday, February 7, 2013 - 11:03am
tags:
Elan, Bayer, M&A, Biogen Idec, Tysabri
The Impending Spinoff of a Spinoff
Motley Fool
Thursday, February 7, 2013 - 11:01am
tags:
AbbVie, Pfizer, Zoetis, Abbott Labs, Covidien
Will The Flu Vaccine Race Send Novartis Higher?
Seeking Alpha
Thursday, February 7, 2013 - 10:59am
tags:
Novartis, vaccines, Flu
GlaxoSmithKline profits down as European sales falter
BBC News
Thursday, February 7, 2013 - 10:58am
tags:
GSK, earnings
A Struggling Endo May Have Another Problem
Pharmalot
Thursday, February 7, 2013 - 10:52am
tags:
Endo Health Solutions
J&J Jury Told Hip Has Many Design Defects Causing Failure
Bloomberg
Thursday, February 7, 2013 - 10:51am
tags:
JNJ, hip implants
Avanir Pharmaceuticals Earnings: An Early Look
Motley Fool
Thursday, February 7, 2013 - 10:49am
tags:
Avanir, earnings
Will Cost Cutting Offset Competitive Pressures For This Biotech In 2013?
Motley Fool
Thursday, February 7, 2013 - 10:22am
tags:
Dendreon, Provenge
Pfizer Breakup Talk Stoked by Discount to Drug Stocks
Bloomberg
Thursday, February 7, 2013 - 10:17am
tags:
Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.